Hemostasis Diagnostic Devices And Equipment Market Growth Accelerates: Strategic Forecast Predicts $10.35 Billion by 2029

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Will the Hemostasis Diagnostic Devices And Equipment Industry Market Size Be by 2025?
The market size of hemostasis diagnostic devices and equipment has experienced rapid growth in the past few years. It's projected to increase from $5.29 billion in 2024 to $6.18 billion in 2025, marking a compound annual growth rate (CAGR) of 16.8%. The surge in the market during the earlier period can be credited to factors such as clinical diagnostics, surgical procedures, the monitoring of anticoagulant therapy, as well as hemophilia and bleeding disorders.

What's the Long-Term Growth Forecast for the Hemostasis Diagnostic Devices And Equipment Market Size Through 2029?
Expectations are high for a swift escalation in the hemostasis diagnostic devices and equipment market in the upcoming years. The market valuation is projected to reach $10.36 billion by 2029, growing at a compound annual growth rate (CAGR) of 13.8%. The anticipated growth within the forecast period is linked to factors such as an aging population, the prevalence of cardiovascular and chronic diseases, advancements in personalized medicine, and an increase in surgical procedures. Forecast period trends to watch out for include point-of-care testing, the rise of automation and robotics, breakthroughs in biomarker discovery, and advancements in telemedicine and remote monitoring.

View the full report here:
https://www.thebusinessresearchcompany.com/report/hemostasis-diagnostic-devices-and-equipment-global-market-report

What Are the Key Growth Drivers Fueling the Hemostasis Diagnostic Devices And Equipment Market Expansion?
A rise in disease diagnosis among senior citizens is propelling the frequency of cardiovascular disease (CVD) surgeries using hemostasis devices. The escalating incidence of illness with age has led to more surgeries being performed on older patients. Hemostasis devices, which effectively expedite the natural clotting process in the blood and provide guidance for anticoagulation and transfusion therapy during surgeries, are commonly used in these procedures. A report by the American Heart Association indicates that Americans over 80 are at a significant risk of CVD - around 83% of men and 87.1% of women are likely to face some form of CVD. As a result, to enhance patient comfort and surgery success rates, hemostasis devices are widely being adopted.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2598&type=smp

What Are the Key Trends Driving Hemostasis Diagnostic Devices And Equipment Market Growth?
The development of advanced technology in the hemostasis diagnostic device and equipment sector is evident. To enhance the effectiveness and precision of surgical procedures, cutting-edge technology such as collagen vascular hemostasis devices are being utilized. Collagen, a primary structural protein found in skin and connective tissues, has become prevalent in the hemostasis diagnostic devices industry, particularly in its purified form for cosmetic surgery treatments. The use of collagen-based closure devices is also on the rise due to issues such as patient immobility and increased discomfort post-femoral surgery. A research study carried out by the American Journal of Neuroradiology surveyed the usage of 698 Angio-Seal closures, noting that the Angio seal shortened the average mobilization time by nearly 15 minutes without any significant complications. The Angio seal, a variant of collagen hemostasis devices, expedites hemostasis and thus improves patient mobility.

How Is the Hemostasis Diagnostic Devices And Equipment Market Segmented?
The hemostasis diagnostic devices and equipment market covered in this report is segmented -

1) By Product: Analyzers, Coagulation Instrument, Other Hemostasis Instruments, Reagents and Kits
2) By Device Technology: Automated, Semi-Automated, Manual
3) By End User: Hospitals, Clinics, Independent Diagnostic, Laboratories, Other End Users

Subsegments:
1) By Analyzers: Hematology Analyzers, Platelet Function Analyzers, Thromboelastography (TEG) Analyzers
2) By Coagulation Instruments: Prothrombin Time (PT) Instruments, Activated Partial Thromboplastin Time (aPTT) Instruments, Fibrinogen Testing Instruments, Thrombin Time (TT) Instruments
3) By Other Hemostasis Instruments: Blood Clotting Time (BCT) Instruments, Bleeding Time (BT) Test Devices, Hemostatic Forceps and Clips
4) By Reagents and Kits: Coagulation Reagents, Blood Collection Kits, Point-of-care Testing Kits, Thrombosis Kits

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=2598&type=smp

Which Companies Are Leading the Charge in Hemostasis Diagnostic Devices And Equipment Market Innovation?
Major companies operating in the hemostasis diagnostic devices and equipment market include C. R. Bard Inc., Baxter International Inc., Pfizer Inc., Johnson & Johnson, Abbott Laboratories, Beckman Coulter Inc., Becton Dickinson and Company, Chrono-Log Corporation, CSL Behring LLC, F. Hoffmann-La Roche Ltd., Grifols S.A., HemCon Medical Technologies Inc., Integra Life Sciences Corporation, Medtronic plc, Siemens AG, Thermo Fisher Scientific Inc., Trinity Biotech plc., Ethicon Inc., Boston Scientific Corporation, Olympus Corporation, Cook Group Inc., Halyard Health, Medline Industries Inc., ConMed Corporation, Moog Inc., Argon Medical Devices Inc., B. Braun Interventional Systems Inc., Bio-Rad Laboratories Inc., CareFusion Corporation, Danaher Corporation, DemeTECH Corporation, Diagnostica Stago SAS, Dolphin Sutures, EndoEvolution LLC, Haemonetics Corporation, Internacional Farmacéutica S.A. de C.V., Merit Medical Systems Inc., Quidelortho Corp, STAGO, Stryker Corporation

Which Regions Are Leading the Global Hemostasis Diagnostic Devices And Equipment Market in Revenue?
North America was the largest region in the global hemostasis diagnostic devices and equipment market in 2023. Asia-Pacific was the second-largest region in the hemostasis diagnostic devices and equipment market. The regions covered in the hemostasis diagnostic devices and equipment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2598

"This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work."

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.